Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31720936 | 1.00 | LMNA (1.00) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL2722025 | 1.00 | LMNA (1.00) | LMNATHRBCA2CA1MMP1 | |
| Perflubron SCHEMBL13724347 | 1.00 | LMNA (1.00) | LMNATHRBCA2CA1MMP1 | |
| Perflubrodec SCHEMBL364093 | 1.00 | LMNA (1.00) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL7029311 | 1.00 | LMNA (1.00) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL7055048 | 1.00 | LMNA (1.00) | LMNATHRBCA2CA1MMP1 | |
| Perflubron SCHEMBL8040555 | 1.00 | LMNA (1.00) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL4511229 | 1.00 | LMNA (1.00) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL249369 | 1.00 | LMNA (1.00) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL248644 | 1.00 | LMNA (1.00) | LMNATHRBCA2CA1MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 15502 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075746-A | Microsphere composition, preparation method thereof and application thereof in preparation of contrast agent and medicine | — | 2026-05-26 | — | — | CN | claimed |
| WO-2026106498-A1 | PERFUSION FLUID, METHODS OF PRODUCING PERFUSION FLUID, AND ITS USES | NanoSanguis S.A. (PL) | 2026-05-21 | — | — | WO | claimed |
| EP-4744486-A1 | PERFUSION FLUID, METHODS OF PRODUCING PERFUSION FLUID, AND ITS USES. | NanoSanguis S.A. (PL) | 2026-05-20 | — | — | EP | claimed |
| EP-4744487-A1 | FLUID, METHODS OF PRODUCING FLUID, AND ITS USES | NanoSanguis S.A. (PL) | 2026-05-20 | — | — | EP | claimed |
| CN-122056850-A | Broad-spectrum targeted virulence factor response type phototherapy nanoparticle, preparation method and application thereof in preparation of antibacterial drugs | 温州医科大学 | 2026-05-19 | — | — | CN | claimed |
| US-12622812-B2 | Otological surgery under perfluorocarbon liquids | ALCON INC. (CH) | 2026-05-12 | — | — | US | claimed |
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| EP-3458037-B1 | FLUOROCHEMICAL TARGETED THERAPIES | MTM RES LLC (US) | 2026-04-29 | — | — | EP | claimed |
| EP-4717278-A1 | NANOVECTORS FOR MAGNETIC RESONANCE IMAGING | Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) | 2026-04-01 | — | — | EP | claimed |
| EP-4704937-A1 | DEVICE FOR THE ENTERAL ABSORPTION OF CO2, AND CORRESPONDING SET | O11 biomedical GmbH (DE) | 2026-03-11 | — | — | EP | claimed |
| EP-0231091-A1 | Stable emulsions of highly fluorinated organic compound | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 1987-08-05 | — | — | EP | claimed |
| EP-0089232-B1 | PERFLUOROCARBON LIQUIDS USEFUL IN EYE TREATMENT AND DIAGNOSTIC PROCEDURES | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 1986-07-02 | — | — | EP | claimed |
| US-4490351-A | REPLACEMENT FOR VITREOUS AND AQUEOUS; TRANSPARENTIZES LENS AND CORNEA; SURGERY; MEDICAL DIAGNOSIS | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 1984-12-25 | — | — | US | claimed |
| EP-0112658-A2 | Extraocular device for treating the eye | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 1984-07-04 | — | — | EP | claimed |
| US-4440745-A | SKIN, DENTIFRICES, POLSHING; COPOLYMER OF POLYALKOXYSILANES AND A HYDROLYZABLE SILANE | FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 1984-04-03 | — | — | US | claimed |
| WO-1983003201-A1 | METHODS OF TREATING THE EYE WITH LIQUID PERFLUOROCARBONS | CHILDRENS HOSP MEDICAL CENTER (US) | 1983-09-29 | — | — | WO | claimed |
| EP-0089232-A2 | Perfluorocarbon liquids useful in eye treatment and diagnostic procedures | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 1983-09-21 | — | — | EP | claimed |
| US-4198287-A | Method of regenerating coke-contaminated catalyst with simultaneous combustion of carbon monoxide | UOP INC. (US) | 1980-04-15 | — | — | US | claimed |
| US-4183962-A | BIOLOGICALLY NONRETAINABLE LIQUID PERHALOCARBON | EXXON RESEARCH & ENGINEERING CO. (US) | 1980-01-15 | — | — | US | claimed |
| US-3951732-A | Delignification and bleaching of wood pulp with oxygen in the presence of triethanolamine | Osakeyhtio, A. Ahlstrom (SF) | 1976-04-20 | — | — | US | claimed |